EDGAR Filing Documents for 0001193125-17-141469

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]

SEC Accession No. 0001193125-17-141469

Filing Date

2017-04-27

Accepted

2017-04-27 10:39:05

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	AMENDMENT NO. 1 TO FORM S-3	d363422ds3a.htm	S-3/A	321174
2	EX-23.1	d363422dex231.htm	EX-23.1	1723
3	EX-23.2	d363422dex232.htm	EX-23.2	1345
	Complete submission text file	0001193125-17-141469.txt		325568

Mailing Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139

Business Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139 (857) 999-0075

KalVista Pharmaceuticals, Inc. (Filer) CIK: 0001348911 (see all company filings)